Review
Copyright ©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Stem Cells. Jan 26, 2015; 7(1): 75-83
Published online Jan 26, 2015. doi: 10.4252/wjsc.v7.i1.75
In vivo imaging of endogenous neural stem cells in the adult brain
Maria Adele Rueger, Michael Schroeter
Maria Adele Rueger, Michael Schroeter, Department of Neurology, University Hospital of Cologne, 50924 Cologne, Germany
Author contributions: All the authors contributed to this work.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Priv.-Doz. Dr. med. Maria Adele Rueger, Department of Neurology, University Hospital of Cologne, Kerpener Strasse 62, 50924 Cologne, Germany. adele.rueger@uk-koeln.de
Telephone: +49-221-47887803 Fax: +49-221-47889143
Received: August 22, 2014
Peer-review started: August 22, 2014
First decision: September 28, 2014
Revised: October 2, 2014
Accepted: October 28, 2014
Article in press: December 16, 2014
Published online: January 26, 2015
Processing time: 145 Days and 9.5 Hours
Abstract

The discovery of endogenous neural stem cells (eNSCs) in the adult mammalian brain with their ability to self-renew and differentiate into functional neurons, astrocytes and oligodendrocytes has raised the hope for novel therapies of neurological diseases. Experimentally, those eNSCs can be mobilized in vivo, enhancing regeneration and accelerating functional recovery after, e.g., focal cerebral ischemia, thus constituting a most promising approach in stem cell research. In order to translate those current experimental approaches into a clinical setting in the future, non-invasive imaging methods are required to monitor eNSC activation in a longitudinal and intra-individual manner. As yet, imaging protocols to assess eNSC mobilization non-invasively in the live brain remain scarce, but considerable progress has been made in this field in recent years. This review summarizes and discusses the current imaging modalities suitable to monitor eNSCs in individual experimental animals over time, including optical imaging, magnetic resonance tomography and-spectroscopy, as well as positron emission tomography (PET). Special emphasis is put on the potential of each imaging method for a possible clinical translation, and on the specificity of the signal obtained. PET-imaging with the radiotracer 3’-deoxy-3’-[18F]fluoro-L-thymidine in particular constitutes a modality with excellent potential for clinical translation but low specificity; however, concomitant imaging of neuroinflammation is feasible and increases its specificity. The non-invasive imaging strategies presented here allow for the exploitation of novel treatment strategies based upon the regenerative potential of eNSCs, and will help to facilitate a translation into the clinical setting.

Keywords: Neural stem cells; Positron emission tomography; Magnetic resonance imaging; 3’-deoxy-3’-[18F]fluoro-L-thymidine; [11C]PK11195

Core tip: Endogenous neural stem cells (eNSCs) in the adult mammalian brain can be mobilized by, e.g., pharmacological methods to facilitate regeneration and enhance functional recovery in neurological disease. In order to translate experimental approaches into the clinical setting, non-invasive imaging of eNSCs is required to monitor their fate in vivo. This review summarizes current imaging modalities suitable to monitor eNSCs in individual experimental animals over time, including optical imaging, magnetic resonance tomography and-spectroscopy, as well as Positron-Emission-Tomography, placing emphasis on the specificity of the signal obtained, as well as on their potential for clinical translation.